SPCG-7 Biopsy study

Post-treatment Prostatic Biopsies after Antiandrogen treatment with or without Radiotherapy

Donec id elit non mi porta gravida at eget metus. Praesent commodo cursus magna, vel scelerisque nisl consectetur et. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Cras mattis consectetur purus sit amet fermentum. Vivamus sagittis lacus vel augue laoreet rutrum faucibus dolor auctor.

Finished

SPCG-7 Biopsy study info

Principal investigator

Anders Widmark and Anders Angelsen

Contact details

Patients

Three years follow-up on SPCG-7/SFUO-3 implemented in centres in Sweden and Norway

Inclusion period

Spring 2002

Number of patients

Aim 200 patients

Sponsor

SPCG

1 publications

Publications of the SPCG-7 Biopsy study trial

Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial

Solberg A, Haugen OA, Viset T, Bergh A, Tasdemir I, Ahlgren G, Widmark A, Angelsen A

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):55-61

Abstract

Post-treatment Prostatic Biopsies after Antiandrogen treatment with or without Radiotherapy

SPCG-7 Biopsy study info

Publications of the SPCG-7 Biopsy study trial

Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial

More trials

SPCG 19/ Get-Randomized- Prostate (Grand-P): A randomized, multi-center trial of immediate curative therapy compared with standard conservative treatment in older men aged ≥ 75 years with non-metastatic, high-risk prostate cancer

Prostate Cancer Active Surveillance Trigger Trial (PCASTT)

No information available

Primary radical prostatectomy versus primary radiotherapy for locally advanced prostate cancer: an open randomized clinical trial

A Randomized, Open Label, Multicenter, Phase III, 2-Arm Study of Androgen Deprivation ± Docetaxel for Non-metastastic Prostate Cancer Patients with a Rising PSA

A Randomized phase III trial of six cycles of docetaxel versus surveillance plus hormonal treatment after radical radiotherapy in patients with intermediate or high-risk prostate cancer (SPCG-13 AdRad)

An open randomised phase III trial of six cycles of docetaxel versus surveillance after radical prostatectomy in prostate cancer patients with high grade pT3 or margin positive pT2

Randomised trial comparing radical prostatectomy versus radiotherapy plus protocol on follow-up of non-randomised patients with localised prostate cancer

Antiandrogen followed by TAB on biochemical progression versus TAB

An open pilot study evaluating intermittent androgen suppression in patients with advanced prostate cancer

Institution of second-line Estracyt therapy at an increase in PSA values for metastatic prostate cancer

Randomized trial of locally advanced prostate cancer. Antiandrogen treatment with or without radiotherapy

A randomized, double-blind, parallel-group trial comparing Casodex 150 mg once daily with placebo in patients with non-metastatic prostate cancer

High-dose Polyestradiol Phosphate versus Total Androgen Blockade

Expectation or radical prostatectomy on early prostate cancer

Cancelled trial due to Socialstyrelsen in Sweden

Orchiectomy plus placebo versus orchiectomy plus cyproteronacetat

Comparison of Estramustine Phosphate to Stilbestrol in the treatment of G3 M Prostatic